Xenetic Biosciences Inc (XBIO)

Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Michael Scott Maguire
Employees:
4
99 HAYDEN AVENUE, SUITE 230, LEXINGTON, MA 02421
781-778-7720

Xenetic Biosciences, Inc. is a clinical stage biopharmaceutical company that is focused on the research and development of certain pharmaceutical products. Its proprietary drug technology platforms include PolyXen for the development of next generation biologic drugs that extend the efficacy, safety and half-life of biologic drugs and OncoHist for the development of novel oncology drugs focused on orphan indications. The company was founded on August 9, 2011 and is headquartered in Lexington, MA.

Data derived from most recent annual or quarterly report
Market Cap 9.812 Million Shares Outstanding13.441 Million Avg 30-day Volume 337.292 Thousand
P/E Ratio0.0 Dividend Yield0.0 EPS-0.13
Price to Revenue29.8448 Debt to Equity0.0 EBITDA-13.909 Million
Price to Book Value1.0678 Operating Margin-3189.8199 Enterprise Value1.516 Million
Current Ratio13.202 EPS Growth0.731 Quick Ratio12.304
1 Yr BETA 1.5402 52-week High/Low 5.68 / 0.45 Profit Margin-2493.1149
Operating Cash Flow Growth33.3189 Altman Z-Score-13.0907 Free Cash Flow to Firm -3.599 Million
View SEC Filings from XBIO instead.

View recent insider trading info

Funds Holding XBIO (via 13F filings)

Refresh Download CSV Download Excel (.xlsx) Download TSV
Filter by:
to
to
to
Refresh
*Shares are split adjusted
*Please note that if a filer hasn't submitted a 13F filing for a quarter then the filer's shares will be listed as "Sold All"

Mutual Funds Holding XBIO BETA

Active Schedule 13D and 13G filings

Please sign in first

Open Market Buys/Sells Last 60 Days

Open Market Buys (P)

none

Open Market Sells (S)

none

Exercise Derivative Conversion (M)

none

Current/Former Insiders

Insider Name Type Last Reported Shares Held Last Reported Date Filings in past year

EISENBERG JEFFREY F CHIEF EXECUTIVE OFFICER

  • Officer
  • Director
100,000 2022-03-24 1

PARSLOW JAMES F CHIEF FINANCIAL OFFICER

  • Officer
50,000 2022-03-24 1

LOCKSHIN CURTIS CHIEF SCIENCIFIC OFFICER

  • Officer
50,000 2022-03-24 1

LOGAL ADAM

  • Director
25,000 2021-12-07 1

KORNBERG ROGER D.

  • Director
25,000 2021-12-07 1

DASTOOR FIRDAUS J.

  • Director
25,000 2021-12-07 1

CALLAWAY JAMES ERIC

  • Director
25,000 2021-12-07 1

VINOGRADOV ALEXEY ANDREEVICH

  • Director
25,000 2021-12-07 1

BORISENKO GRIGORY G.

  • Director
0 2019-09-26 0

GENKIN DMITRY

  • Director
93,603 2019-07-19 0

DEPTULA-HICKS DARLENE M

  • Director
No longer subject to file 2017-08-09 0

BENZ EDWARD J. JR

  • Director
No longer subject to file 2017-08-09 0

MAGUIRE MICHAEL SCOTT CEO

  • Officer
  • Director
0 2016-12-20 0

KNYAZEV ROMAN

  • Director
0 2016-11-01 0

PJSC PHARMSYNTHEZ

  • 10% Owner
7,790,600 2014-01-23 0

LLC SYNBIO

  • 10% Owner
1,791,567 2014-01-23 0

Insider Transactions Last 60 Days

Reporting Owners Filing Date Trans Date Trans Code Shares Share Price Acquired
Disposed
Shares Owned after D/I 10b5 Perf 1d* Perf 5d* Perf 1m* Max Gain Max Gain Days Max Loss Max Loss Days

PARSLOW JAMES F - Officer CHIEF FINANCIAL OFFICER

2022-03-28 17:14:50 -0400 2022-03-24 A 50,000 a 50,000 direct

EISENBERG JEFFREY F - Director - Officer CHIEF EXECUTIVE OFFICER

2022-03-28 17:16:48 -0400 2022-03-24 A 100,000 a 100,000 direct

LOCKSHIN CURTIS - Officer CHIEF SCIENCIFIC OFFICER

2022-03-28 17:13:39 -0400 2022-03-24 A 50,000 a 50,000 direct

* -

Transaction Code Definitions
Code Definition
A Grant, award or other acquisition pursuant to Rule 16b-3(d)
C Conversion of derivative security
D Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e)
E Expiration of short derivative position
F Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3
G Bona fide gift
H Expiration (or cancellation) of long derivative position with value received
I Discretionary transaction in accordance with Rule 16b-3(f) resulting in acquisition or disposition of issuer securities
J Other acquisition or disposition
L Small acquisition under Rule 16a-6
M Exercise or conversion of derivative security exempted pursuant to Rule 16b-3
O Exercise of out-of-the-money derivative security
P Open market or private purchase of non-derivative or derivative security
S Open market or private sale of non-derivative or derivative security
U Disposition pursuant to a tender of shares in a change of control transaction
W Acquisition or disposition by will or the laws of descent and distribution
X Exercise of in-the-money or at-the-money derivative security
Z Deposit into or withdrawal from voting trust

IBR Securities Loan Availability

Updated throughout the day, this shows the number of shares available to borrow. Data provided by Interactive Brokers

Security Date/Time Rebate Rate Fee Rate Shares Available
XENETIC BIOSCIENCES INC XBIO 2022-05-20 22:15:03 UTC -60.0371 60.8571 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 21:45:03 UTC -60.0371 60.8571 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 21:15:03 UTC -60.0371 60.8571 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 20:45:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 20:15:05 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 19:45:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 19:15:04 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 18:45:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 18:15:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 17:45:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 17:15:03 UTC -66.0263 66.8463 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 16:45:04 UTC -67.7547 68.5747 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 16:15:03 UTC -67.7547 68.5747 700000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 15:45:03 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 15:15:03 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 14:45:03 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 14:15:04 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 13:45:03 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 13:15:03 UTC -67.7547 68.5747 650000
XENETIC BIOSCIENCES INC XBIO 2022-05-20 12:45:03 UTC -67.7547 68.5747 650000

Current Active Short Positions

Holder Issuer Net Short Position Position Date Origin

Elevate your investments